DNA
Price
$10.79
Change
-$0.28 (-2.53%)
Updated
Jul 10 closing price
Capitalization
647.95M
LTRN
Price
$3.51
Change
+$0.12 (+3.54%)
Updated
Jul 10 closing price
Capitalization
36.56M
26 days until earnings call
Interact to see
Advertisement

DNA vs LTRN

Header iconDNA vs LTRN Comparison
Open Charts DNA vs LTRNBanner chart's image
Ginkgo Bioworks Holdings
Price$10.79
Change-$0.28 (-2.53%)
Volume$987.31K
Capitalization647.95M
Lantern Pharma
Price$3.51
Change+$0.12 (+3.54%)
Volume$64.87K
Capitalization36.56M
DNA vs LTRN Comparison Chart in %
Loading...
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNA vs. LTRN commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNA is a Buy and LTRN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (DNA: $10.79 vs. LTRN: $3.51)
Brand notoriety: DNA and LTRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNA: 77% vs. LTRN: 40%
Market capitalization -- DNA: $647.95M vs. LTRN: $36.56M
DNA [@Biotechnology] is valued at $647.95M. LTRN’s [@Biotechnology] market capitalization is $36.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNA’s FA Score shows that 1 FA rating(s) are green whileLTRN’s FA Score has 1 green FA rating(s).

  • DNA’s FA Score: 1 green, 4 red.
  • LTRN’s FA Score: 1 green, 4 red.
According to our system of comparison, DNA is a better buy in the long-term than LTRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNA’s TA Score shows that 6 TA indicator(s) are bullish while LTRN’s TA Score has 5 bullish TA indicator(s).

  • DNA’s TA Score: 6 bullish, 4 bearish.
  • LTRN’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, LTRN is a better buy in the short-term than DNA.

Price Growth

DNA (@Biotechnology) experienced а -15.17% price change this week, while LTRN (@Biotechnology) price change was +8.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

DNA is expected to report earnings on May 06, 2025.

LTRN is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNA($648M) has a higher market cap than LTRN($36.6M). LTRN (10.031) and DNA (9.878) have similar YTD gains . LTRN has higher annual earnings (EBITDA): -21.24M vs. DNA (-387.59M). DNA has more cash in the bank: 517M vs. LTRN (19.7M). LTRN has less debt than DNA: LTRN (195K) vs DNA (435M). DNA has higher revenues than LTRN: DNA (237M) vs LTRN (0).
DNALTRNDNA / LTRN
Capitalization648M36.6M1,770%
EBITDA-387.59M-21.24M1,825%
Gain YTD9.87810.03198%
P/E RatioN/AN/A-
Revenue237M0-
Total Cash517M19.7M2,624%
Total Debt435M195K223,077%
TECHNICAL ANALYSIS
Technical Analysis
DNALTRN
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 29 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMCX48.09N/A
N/A
Congress Small Cap Growth Institutional
DURCX13.98N/A
N/A
DWS ESG International Core Eq C
ANDVX10.58N/A
N/A
Virtus NFJ Dividend Value R6
POIIX16.74N/A
N/A
Polen International Growth Institutional
TMPRX56.97N/A
N/A
Touchstone Mid Cap R6

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with MNMD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
+3.54%
MNMD - LTRN
36%
Loosely correlated
+4.92%
AXON - LTRN
36%
Loosely correlated
-9.04%
RXRX - LTRN
35%
Loosely correlated
+2.24%
ABSI - LTRN
34%
Loosely correlated
-3.53%
ATAI - LTRN
34%
Loosely correlated
+2.63%
More